Therapeutic Drug Monitoring of Protein Kinase Inhibitors in the Treatment of Non-small Cell Lung Cancer
Targeted therapy with protein kinase inhibitors (PKIs) represents one of the important treatment options for non-small cell lung cancer (NSCLC). It has contributed to improve patients’ survival and quality of life significantly. These anticancer drugs are administrated orally in flat-fixed doses des...
| المؤلفون الرئيسيون: | , , , |
|---|---|
| التنسيق: | مقال |
| اللغة: | English |
| منشور في: |
Karolinum Press
2023-09-01
|
| سلاسل: | Prague Medical Report |
| الوصول للمادة أونلاين: | https://pmr.lf1.cuni.cz/124/3/0199/ |